CZYH Alleviates β-Amyloid-Induced Cognitive Impairment and Inflammation Response via Modulation of JNK and NF-κB Pathway in Rats.
In conclusion, the present study suggests that CZYH could improve learning and memory abilities and relieve neuron loss in Aβ 25-35-induced rats, at least partly through inhibition of the neuroinflammatory response via inhibiting the JNK-dependent NF-κB activation, indicating that CZYH might be a promising formula for the treatment of AD.
PMID: 31781295 [PubMed - in process]
Source: Behavioural Neurology - Category: Neurology Authors: Deng Y, Ye L, Yu C, Yin C, Shi J, Gong Q Tags: Behav Neurol Source Type: research
More News: Amnesia | Brain | China Health | Donepezil | Learning | Neurology | Study | Universities & Medical Training